General MedicationsINTRAVENOUSStandard
ATROPINE SULFATE
ATROPINE SULFATE
Standard Dose
1MG/10ML (0.1MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview ATROPINE SULFATE is listed in Drugs@FDA under application 215342 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient ATROPINE SULFATE Form and strength SOLUTION;INTRAVENOUS - 1MG/10ML (0.1MG/ML) Sponsor AMNEAL Submission history Latest submission status date: 2022-01-26 00:00:00.
Structured Monograph
Clinical summary
Approval overview ATROPINE SULFATE is listed in Drugs@FDA under application 215342 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ATROPINE SULFATE Form and strength SOLUTION;INTRAVENOUS - 1MG/10ML (0.1MG/ML) Sponsor AMNEAL Submission history Latest submission status date: 2022-01-26 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.